Usefulness of vortioxetine noted in depression secondary to hypoxic brain injury and residual cognitive deficits.

Ther Adv Psychopharmacol

Consultant General Adult Psychiatry, Oxleas NHS Foundation Trust, 1-6 Carlton Parade, Orpington, London BR60JB, UK.

Published: August 2020

We report on our experience of treating depression secondary to hypoxic brain injury with the antidepressant vortioxetine to share in the growing body of evidence. Our patient was referred to a community mental health team with depression, amotivation and memory difficulties following a myocardial infarction and cardiac arrest 2 years prior. Regardless of motor recovery, major cognitive deficits remained; however, neurorehabilitation was impossible due to severe depression. We tried vortioxetine in the light of two failed antidepressants and saw a remarkable improvement in mood, motivation and engagement.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446252PMC
http://dx.doi.org/10.1177/2045125320943399DOI Listing

Publication Analysis

Top Keywords

depression secondary
8
secondary hypoxic
8
hypoxic brain
8
brain injury
8
cognitive deficits
8
vortioxetine depression
4
injury residual
4
residual cognitive
4
deficits report
4
report experience
4

Similar Publications

Objectives: To investigate potential sleep inequities between the infants of Māori and non-Māori mothers in Aotearoa New Zealand, identify socio-ecological factors associated with infant sleep, and determine features of infant sleep that contribute to a mother-perceived infant sleep problem.

Design: Secondary analysis of longitudinal data from the Moe Kura: Mother and Child, Sleep and Well-being in Aotearoa New Zealand study when infants were approximately 12 weeks old.

Participants: 383 Māori and 702 non-Māori mother-infant dyads.

View Article and Find Full Text PDF

Three-year-old development: The relationship of child health and parenting stress to neurocognition.

J Pediatr Nurs

January 2025

Department of Health Promotion and Disease Prevention, College of Nursing, University of Tennessee Health Science Center, 847 Union Ave, Memphis, TN 38163, USA.

Purpose: This study examined parenting stress and child special healthcare needs to child neurocognitive development (NCD).

Design And Methods: This secondary analysis used data from the primary study, a longitudinal cohort study of mother-child dyads. Multivariable regression models examined the associations between parenting stress and child special healthcare needs with NCD.

View Article and Find Full Text PDF

Understanding structural-functional connectivity coupling in patients with major depressive disorder: A white matter perspective.

J Affect Disord

January 2025

Department of Radiology, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong 264000, PR China; Shandong Provincial Key Medical and Health Laboratory of Intelligent Diagnosis and Treatment for Women's Diseases (Yantai Yuhuangding Hospital), Yantai, Shandong 264000, PR China; Big Data and Artificial Intelligence Laboratory, Yantai Yuhuangding Hospital, Qingdao University, Yantai, Shandong 264000, PR China. Electronic address:

Purpose: To elucidate the structural-functional connectivity (SC-FC) coupling in white matter (WM) tracts in patients with major depressive disorder (MDD).

Methods: A total of 178 individuals diagnosed with MDD and 173 healthy controls (HCs) were recruited for this study. The Euclidean distance was calculated to assess SC-FC coupling.

View Article and Find Full Text PDF

Effect of transcutaneous vagus nerve stimulation in hemodialysis patients: A randomized controlled trial.

Ther Apher Dial

January 2025

Department of Nephrology, The Third Clinical Medical College of China Three Gorges University, Sinopharm Gezhouba Central Hospital, Yichang, China.

Introduction: Transcutaneous auricular vagus nerve stimulation (tVNS) has shown potential in neurological, autoimmune, and cardiovascular disorders, but its effects on HD patients remain unclear. This study aimed to evaluate the efficacy and safety of tVNS in HD patients.

Methods: We conducted a randomized controlled clinical trial on patients receiving HD ≥6 months.

View Article and Find Full Text PDF

Background: Adults with ADHD benefit from treatment with extended-release (ER) formulations that provide symptom control for the entire day. Some patients are advised to supplement their extended-release medication with an immediate-release (IR) medication later in the day if they need to prolong its effects. Given that several FDA-approved ER formulations are available and many individual patient variables may affect efficacy, the purpose of this study was to identify reliable predictors of the tendency for patients to supplement their daily ER medication with an IR medication.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!